Diagnosing Alzheimer’s Disease – Project granted with more than €1.3 million in aid under the Colaboración Público Privada Program
Destina Genomica SL is part of a consortium formed by the Foundation for Biomedical Research of the Ramón y Cajal…
Destina Genomica SL is part of a consortium formed by the Foundation for Biomedical Research of the Ramón y Cajal…
We are excited to announce a new project that changes the way we analyze miRNA-122. This small non-coding RNA is…
DESTINA Genomics and Mecwins join forces to develop more reliable diagnostic tests Both biotechnology firms have signed a cross-licensing…
DESTINA Genomica SL has joined @Science Exchange, the global platform for outsourced R&D reagents and services. For quotations on the…
DESTINA Genomics has a new redesigned and upgraded website at www.destinagenomics.com Now live, the modernised web design makes access easy…
Novel molecular assay based on ‘Single Nucleotide Fingerprints’ (SNF) for the diagnosis and monitoring of Trypanosomatids. EDINBURGH, UK and GRANADA,…